Trans Ova Genetics (TOG) offers industry-leading reproductive technologies and expertise to cattle breeders, aiding them in advancing and extending superior genetics. The company provides a range of reproductive technologies such as embryo transfer, in-vitro fertilization (IVF), sexed-semen, genetic preservation, and cloning. Their integrated system of regional centers, satellite stations, and on-farm application of these technologies sets them apart as an internationally recognized source of superior animal husbandry and reproductive expertise.
The company, founded in 1980 and headquartered in the United States, boasts a unique professional services team that collaborates closely with clients to understand their breeding goals, multiplying their genetic success. The dedication to client service and ongoing research places TOG at the forefront of bovine genetic improvement, constantly developing and implementing new technologies to meet customer requirements and to ensure continual improvement.
Trans Ova Genetics stands as a pioneering force in the biotechnology and health care industries, signaling potential for significant impact and growth. While information on its latest investment and investors is not available, the company’s commitment to innovation and customer satisfaction positions it as a notable player in the field, potentially attracting interest from venture capital firms seeking promising opportunities in the biotechnology sector.
There is no investment information
No recent news or press coverage available for Trans Ova Genetics.